Prospective comparison of a commercial multiplex real-time polymerase chain reaction and an enzyme immunoassay with toxigenic culture in the diagnosis of Clostridium difficile-associated infections

Diagnostic Microbiology and Infectious Disease

Volumn 75, Issue 4, 2013, Pages 361-365

  Hernández Rocha, Cristian ^a   Barra Carrasco, Jonathan ^b   Álvarez Lobos, Manuel ^a   Paredes Sabja, Daniel ^b,c   Guzmán Durán, Ana María ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c OREGON STATE UNIVERSITY   (United States)

Author keywords

Clostridium difficile; EIA; Real time PCR; Toxigenic culture

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; BACTERIUM EXAMINATION; BROTH ENRICHMENT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FECES ANALYSIS; FEMALE; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEUTRALIZATION ASSAY; POLYMERASE CHAIN REACTION KIT; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TOXIGENIC CULTURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, BACTERIAL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; DNA, BACTERIAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84875243638     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2012.12.010     Document Type: Article

References (39)

1. Ananthakrishnan A.N. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol 2011, 8:17-26.
2. Balassiano I.T., Yates E.A., Domingues R.M., Ferreira E.O. Clostridium difficile: a problem of concern in developed countries and still a mystery in Latin America. J Med Microbiol 2012, 61:169-179.
3. Borgmann S., Kist M., Jakobiak T., Reil M., Scholz E., von Eichel-Streiber C., Gruber H., Brazier J.S., Schulte B. Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill 2008, 13.
4. Boyanton B.L., Sural P., Loomis C.R., Pesta C., Gonzalez-Krellwitz L., Robinson-Dunn B., Riska P. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection. J Clin Microbiol 2012, 50:640-645.
5. Cohen S.H., Gerding D.N., Johnson S., Kelly C.P., Loo V.G., McDonald L.C., Pepin J., Wilcox M.H. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010, 31:431-455.
6. Doing K.M., Hintz M.S., Keefe C., Horne S., LeVasseur S., Kulikowski M.L. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures. Diagn Microbiol Infect Dis 2010, 66:129-134.
7. Eastwood K., Else P., Charlett A., Wilcox M. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 2009, 47:3211-3217.
8. Gerding D.N. Global epidemiology of Clostridium difficile infection in 2010. Infect Control Hosp Epidemiol 2010, 31(Suppl 1):S32-34.
9. Goldenberg S.D., Dieringer T., French G.L. Detection of toxigenic Clostridium difficile in diarrheal stools by rapid real-time polymerase chain reaction. Diagn Microbiol Infect Dis 2010, 67:304-307.
10. Hernández-Rocha C., Barra-Carrasco J., Pizarro-Guajardo M., Ibánez P., Bueno S.M., Sarker M.R., Guzman A.M., Álvarez-Lobos M., Paredes-Sabja D. Clostridium difficile epidemic ribotype 027 in Chile. Emerg Infect Dis 2012, 18:1370-1373.
11. Hernández-Rocha C., Naour S., Álvarez-Lobos M., Paredes-Sabja D. Infecciones causadas por Clostridium difficile: una visión actualizada. Rev Chilena Infectol 2012, 29:434-445.
12. Herrera P., Cotera A., Fica A., Galdo T., Alvo M. High incidence and complications of Clostridium difficile diarrhea among patients with renal diseases. Rev Med Chil 2003, 131:397-403.
13. Hookman P., Barkin J.S. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009, 15:1554-1580.
14. Karas J.A., Enoch D.A., Aliyu S.H. A review of mortality due to Clostridium difficile infection. J Infect 2010, 61:1-8.
15. Kuijper E.J., Coignard B., Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006, 12(Suppl 6):2-18.
16. Kvach E.J., Ferguson D., Riska P.F., Landry M.L. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J Clin Microbiol 2010, 48:109-114.
17. Larson A.M., Fung A.M., Fang F.C. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J Clin Microbiol 2010, 48:124-130.
18. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., Bourgault A.M., Nguyen T., Frenette C., Kelly M., Vibien A., Brassard P., Fenn S., Dewar K., Hudson T.J., Horn R., Rene P., Monczak Y., Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442-2449.
19. Morelli M.S., Rouster S.D., Giannella R.A., Sherman K.E. Clinical application of polymerase chain reaction to diagnose Clostridium difficile in hospitalized patients with diarrhea. Clin Gastroenterol Hepatol 2004, 2:669-674.
20. Novak-Weekley S.M., Marlowe E.M., Miller J.M., Cumpio J., Nomura J.H., Vance P.H., Weissfeld A. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J Clin Microbiol 2010, 48:889-893.
21. Pancholi P., Kelly C., Raczkowski M., Balada-Llasat J.M. Detection of toxigenic Clostridium difficile: comparison of the cell culture neutralization, Xpert C. difficile, Xpert C. difficile/Epi, and Illumigene C. difficile assays. J Clin Microbiol 2012, 50:1331-1335.
22. Pepin J., Saheb N., Coulombe M.A., Alary M.E., Corriveau M.P., Authier S., Leblanc M., Rivard G., Bettez M., Primeau V., BNguyen M., Jacob C.E., Lanthier L. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254-1260.
23. Pepin J., Valiquette L., Cossette B. Mortality attributable to nosocominal Clostridium difficile-associated disease during epidemic caused by a hypervirulent strain in Quebec. CMAJ 2005, 173:1037-1042.
24. Peterson L.R., Manson R.U., Paule S.M., Hacek D.M., Robicsek A., Thomson R.B., Kaul K.L. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007, 45:1152-1160.
25. Planche T., Aghaizu A., Holliman R., Riley P., Poloniecki J., Breathnach A., Krishna S. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 2008, 8:777-784.
26. Quesada-Gomez C., Rodriguez C., Gamboa-Coronado Mdel M., Rodriguez-Cavallini E., Du T., Mulvey M.R., Villalobos-Zuniga M., Boza-Cordero R. Emergence of Clostridium difficile NAP1 in Latin America. J Clin Microbiol 2010, 48:669-670.
27. Quinn C.D., Sefers S.E., Babiker W., He Y., Alcabasa R., Stratton C.W., Carroll K.C., Tang Y.W. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J Clin Microbiol 2010, 48:603-605.
28. Reller M.E., Lema C.A., Perl T.M., Cai M., Ross T.L., Speck K.A., Carroll K.C. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J Clin Microbiol 2007, 45:3601-3605.
29. Rupnik M. Clostridium difficile toxinotyping. Methods Mol Biol 2010, 646:67-76.
30. Rupnik M., Wilcox M.H., Gerding D.N. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009, 7:526-536.
31. Sarker M.R., Paredes-Sabja D. Molecular basis of early stages of Clostridium difficile infection: germination and colonization. Future Microbiol 2012, 7:933.
32. Sharp S.E., Ruden L.O., Pohl J.C., Hatcher P.A., Jayne L.M., Ivie W.M. Evaluation of the C. Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J Clin Microbiol 2010, 48:2082-2086.
33. Shin S., Kim M., Lim H., Kim H., Lee K., Chong Y. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med 2012, 32:355-358.
34. Snell H., Ramos M., Longo S., John M., Hussain Z. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 2004, 42:4863-4865.
35. Swindells J., Brenwald N., Reading N., Oppenheim B. Evaluation of diagnostic tests for Clostridium difficile infection. J Clin Microbiol 2010, 48:606-608.
36. Terhes G., Urban E., Soki J., Nacsa E., Nagy E. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J Clin Microbiol 2009, 47:3478-3481.
37. Viala C., Le Monnier A., Maataoui N., Rousseau C., Collignon A., Poilane I. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile. J Microbiol Methods 2012, 90:83-85.
38. Wilcox M.H., Planche T., Fang F.C., Gilligan P. What is the current role of algorithmic approaches for diagnosis of Clostridium difficile infection?. J Clin Microbiol 2010, 48:4347-4353.
39. Zilberberg M.D., Shorr A.F., Kollef M.H. Increase in adult Clostrdium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg Infect Dis 2008, 14:929-931.